Skip to content

Multi-Center Trial to Evaluate an Internal Joint Stabilizer - Elbow

Multi-Center Trial to Evaluate an Internal Joint Stabilizer - Elbow (IJS-E)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01944670
Enrollment
26
Registered
2013-09-18
Start date
2013-08-31
Completion date
2015-09-30
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Elbow Dislocation, Trauma

Brief summary

The purpose of this study is to confirm the safety and effectiveness of the Internal Joint Stabilizer - Elbow.

Interventions

DEVICEInternal Joint Stabilizer - Elbow (IJS-E)

Device designed for internal stabilization of the elbow

Sponsors

Skeletal Dynamics, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The subject is \>21 years of age. * The subject is considered a candidate for the Internal Joint Stabilizer -Elbow (IJS-E) under one of the following indications: * Subjects where either the elbow sublocates or dislocates after repairing the injured ligaments and/or bones * The elbow has been subluxated or dislocated for more than 10 days prior to surgery * The elbow subluxes or dislocates after surgical repair/reconstruction * The subject has sufficient quantity or quality of bone. Specifically there is sufficient trochlea of the distal humerus and of sufficient quality that the axis pin of the IJS-E has a secure hold as judged by the surgeon intra-operatively. Also, the screws placed in the ulna must be judged by the surgeon to have sufficient hold. * The subject or legal guardian has been informed of the nature of the study, agrees to its provisions, and has provided informed written consent. * The subject is willing to be available for the appropriate follow-up for the duration of the study.

Exclusion criteria

* The subject has one of the following conditions: * Presents with limited elbow motion as opposed to instability (subjects where instability is created through surgical release for chronic limitation of movement, soft tissue release, removal of adhesions and heterotopic ossification and/or fascial interposition will be excluded). * Active infection, suspicion of colonization or quiescent infection * Bacteremia * Bone loss greater than 30% of the total articulation or involving an entire column of the distal humerus * The subject has less than 50% of the height of the coronoid remaining, based on lateral x-ray view * Osteoporosis to the degree that the screws that insert into the ulna loosen during implantation * Material sensitivity to titanium or cobalt chrome * The subject has imminent, known issues related to life expectancy. * The subject is unable and/or unwilling to cooperate with study procedures, a rehabilitative program, or required follow-up visits. * The subject has a condition that may interfere with the outcome or impede healing. * The subject, in the opinion of the Clinical Investigator, has an existing condition that indicates he/she is not a good candidate for the study. * The subject is unable or unwilling to give informed consent and/or who has no responsible family member willing to give consent. * The subject is transient and has no fixed address. * The subject is a prisoner. * The subject is \<21 years of age, or \>21 years of age but skeletally immature.

Design outcomes

Primary

MeasureTime frameDescription
Broberg Morrey Functional RatingEight months (6 months post-explant)To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients receive a Broberg Morrey Functinoal Rating of Fair or better.
Recurrent Dislocations8 months (6 month post-explant)To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients do not have a recurrent dislocation while using the IJS-E or after removal of the IJS-E.

Countries

United States

Participant flow

Participants by arm

ArmCount
Internal Joint Stabilizer Group
Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) Internal Joint Stabilizer - Elbow (IJS-E): Device designed for internal stabilization of the elbow
26
Total26

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2

Baseline characteristics

CharacteristicInternal Joint Stabilizer Group
Age, Continuous57.1 years
STANDARD_DEVIATION 18.6
Height (in)65.8 inches
STANDARD_DEVIATION 4
Operative Side
Dominant Hand (including ambidextrous patients)
9 Participants
Operative Side
Non-dominant Hand
17 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
12 Participants
Side Dominance
Ambidextrous
1 Participants
Side Dominance
Left Handed
1 Participants
Side Dominance
Right Handed
24 Participants
Subluxed or Dislocated
Dislocated
19 Participants
Subluxed or Dislocated
Subluxed
7 Participants
Weight (lbs)188.0 lbs
STANDARD_DEVIATION 41.2

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 24
serious
Total, serious adverse events
0 / 24

Outcome results

Primary

Broberg Morrey Functional Rating

To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients receive a Broberg Morrey Functinoal Rating of Fair or better.

Time frame: Eight months (6 months post-explant)

Population: Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) who completed the study (have final follow-up data). Excludes patients who were lost to follow-up.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Participants Who Completed the StudyBroberg Morrey Functional RatingBroberg Morrey Score of Excellent14 Participants
Participants Who Completed the StudyBroberg Morrey Functional RatingBroberg Morrey Score of Good8 Participants
Participants Who Completed the StudyBroberg Morrey Functional RatingBroberg Morrey Score of Fair1 Participants
Participants Who Completed the StudyBroberg Morrey Functional RatingBroberg Morrey Score of Poor1 Participants
Primary

Recurrent Dislocations

To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients do not have a recurrent dislocation while using the IJS-E or after removal of the IJS-E.

Time frame: 8 months (6 month post-explant)

Population: Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) who completed the study (have final follow-up data). Excludes patients who were lost to follow-up.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Participants Who Completed the StudyRecurrent Dislocations0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026